A. Piga

851 total citations
38 papers, 651 citations indexed

About

A. Piga is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Piga has authored 38 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Piga's work include Cancer Diagnosis and Treatment (9 papers), Biochemical and Molecular Research (7 papers) and Medical Imaging and Pathology Studies (5 papers). A. Piga is often cited by papers focused on Cancer Diagnosis and Treatment (9 papers), Biochemical and Molecular Research (7 papers) and Medical Imaging and Pathology Studies (5 papers). A. Piga collaborates with scholars based in Italy, United Kingdom and Vietnam. A. Piga's co-authors include Fabio Puglisi, A. V. Hoffbrand, K. Ganeshaguru, Claudia Andreetta, R. Cellerino, H. G. Prentice, Alessandro Marco Minisini, Stefania Russo, Alessandro Follador and Giovanni Gerardo Cardellino and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

A. Piga

37 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Piga Italy 14 308 183 142 99 93 38 651
G. Ucci Italy 19 355 1.2× 357 2.0× 137 1.0× 62 0.6× 65 0.7× 61 931
B M Sanders United Kingdom 10 413 1.3× 227 1.2× 89 0.6× 115 1.2× 105 1.1× 11 1.0k
Mario Roberto Sertoli Italy 17 652 2.1× 188 1.0× 176 1.2× 32 0.3× 166 1.8× 32 1000
Steve Nicholson United Kingdom 16 330 1.1× 361 2.0× 89 0.6× 87 0.9× 54 0.6× 34 994
G Auclerc France 13 551 1.8× 165 0.9× 296 2.1× 47 0.5× 123 1.3× 56 933
Daniel Oruzio Germany 14 426 1.4× 89 0.5× 72 0.5× 40 0.4× 49 0.5× 30 658
R Lahtinen Finland 17 530 1.7× 247 1.3× 37 0.3× 141 1.4× 79 0.8× 31 1.1k
C. Tropé Norway 19 215 0.7× 156 0.9× 219 1.5× 105 1.1× 34 0.4× 44 1.0k
W. Schröder Germany 18 274 0.9× 299 1.6× 255 1.8× 91 0.9× 78 0.8× 57 1.3k
Penny J. Barnes Canada 18 349 1.1× 105 0.6× 288 2.0× 132 1.3× 71 0.8× 45 874

Countries citing papers authored by A. Piga

Since Specialization
Citations

This map shows the geographic impact of A. Piga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Piga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Piga more than expected).

Fields of papers citing papers by A. Piga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Piga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Piga. The network helps show where A. Piga may publish in the future.

Co-authorship network of co-authors of A. Piga

This figure shows the co-authorship network connecting the top 25 collaborators of A. Piga. A scholar is included among the top collaborators of A. Piga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Piga. A. Piga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonoldi, Emanuela, Sabrina Buoro, Michele Cerati, et al.. (2024). Digital transition in pathology lab: a survey from the Lombardy region. Pathologica. 116(4). 232–241.
2.
Andreetta, Claudia, Cinzia Puppin, Francesca Valent, et al.. (2008). Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Annals of Oncology. 20(2). 265–271. 48 indexed citations
3.
Menis, Jessica, Claudia Andreetta, Francesca Valent, et al.. (2008). Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era. Journal of Clinical Oncology. 26(15_suppl). 631–631. 1 indexed citations
4.
Bracci, R., R. Cellerino, Rosaria Gesuita, et al.. (2008). Information to cancer patients: a questionnaire survey in three different geographical areas in Italy. Supportive Care in Cancer. 16(8). 869–877. 16 indexed citations
5.
Puglisi, Fabio, Cinzia Puppin, Enrico Pegolo, et al.. (2007). Expression of periostin in human breast cancer. Journal of Clinical Pathology. 61(4). 494–498. 80 indexed citations
6.
Puglisi, Fabio, Alessandro Follador, Alessandro Marco Minisini, et al.. (2005). Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Annals of Oncology. 16(2). 263–266. 108 indexed citations
7.
Piga, A., Rolando Nortilli, Gian Luigi Cetto, et al.. (2004). Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site. British Journal of Cancer. 90(10). 1898–1904. 19 indexed citations
8.
Scartozzi, Mario, Michele De Nictolis, Gennaro Galizia, et al.. (2003). Loss of hMLH1 expression correlates with improved survival in stage III–IV ovarian cancer patients. European Journal of Cancer. 39(8). 1144–1149. 28 indexed citations
9.
Thirion, P., Pascal Piedbois, Marc Buyse, et al.. (2001). Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer. British Journal of Cancer. 84(5). 611–620. 23 indexed citations
10.
Piga, A., et al.. (1997). A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma. Cancer Immunology Immunotherapy. 44(6). 348–351. 6 indexed citations
11.
Piga, A., et al.. (1994). Metastatic tumor of unknown primary site. Annals of Oncology. 5(9). 841–845. 1 indexed citations
12.
Piga, A., et al.. (1994). Drug resistance in tumor cells.. PubMed. 18(3). 330–9. 4 indexed citations
13.
Giovagnoni, Andrea, et al.. (1994). MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion.. American Journal of Roentgenology. 163(5). 1093–1097. 13 indexed citations
14.
Congiu, Angela Giovanna, et al.. (1994). Thyroid and skin metastases from renal carcinoma. 49(3). 223–227. 1 indexed citations
15.
Cellerino, R., et al.. (1993). The teaching of clinical oncology in Italian medical schools. A survey among teachers and students. Annals of Oncology. 4(9). 717–721. 18 indexed citations
16.
Ganeshaguru, K., A. Piga, Luciano Latini, & A. V. Hoffbrand. (1989). Inability of Poly-ADP-Ribosylation Inhibitors to Protect Peripheral Blood Lymphocytes from the Toxic Effects of ADA Inhibition. Advances in experimental medicine and biology. 253B. 251–258. 3 indexed citations
17.
Piga, A., et al.. (1989). Pyrimidine 5′-Nucleotidase Acquired Deficiency in β-Thalassemia: Involvement of Enzyme-SH Groups in the Inactivation Process. Acta Haematologica. 82(2). 69–74. 11 indexed citations
18.
Piga, A., et al.. (1985). Phytohemagglutinin-induced changes in tyrosine protein kinase and its endogenous substrates in human lymphocytes. Experimental Cell Research. 159(1). 103–112. 14 indexed citations
19.
Cooper, E.H., M A Forbes, M A Chamberlain, V. Gabutti, & A. Piga. (1984). Plasma Beta-2-Microglobulin and Fibronectin Levels in Beta-Thalassaemia. Acta Haematologica. 71(4). 257–262. 5 indexed citations
20.
Piga, A., et al.. (1981). DNA Synthesis in Thymic‐Acute Lymphoblastic Leukaemia. British Journal of Haematology. 48(4). 585–594. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026